Paraplatin Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Paraplatin: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

CARBOPLATIN (KAR boe pla tin) is a chemotherapy drug. It targets fast dividing cells, like cancer cells, and causes these cells to die. This medicine is used to treat ovarian cancer and many other cancers.

In-Depth Information
Select a Medication

Paraplatin 450mg/45ml Solution for Injection

NDC: 000153212
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Wilms' Tumor, Small Cell Lung Cancer (SCLC), Non-Hodgkin's Lymphoma (NHL), Malignant Glioma, Thymoma, Thymic Carcinoma, Neuroblastoma, Acute Lymphocytic Leukemia (ALL), Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, Breast Cancer, Testicular Cancer, Stem Cell Transplant Preparation, Glioblastoma Multiforme, Head And Neck Cancer, Bladder Cancer

Storage Information
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Paraplatin 450mg/45ml Solution for Injection

Reported Side Effects for Paraplatin 450mg/45ml Solution for Injection

Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Skin Redness Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Anemia Incidence:
<14.0%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
3.0-49.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
5.0-16.0%*
Severity: MILD
Onset: DELAYED
Bleeding Incidence:
5.0-8.0%*
Severity: MODERATE
Onset: EARLY
High Bilirubin Level Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
10.0-93.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
11.0-41.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
15.0-71.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
15.0-20.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
16.0-82.0%*
Severity: SEVERE
Onset: DELAYED
Low Potassium Levels Incidence:
20.0%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
22.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
25.0-33.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
29.0%*
Severity: MODERATE
Onset: DELAYED
Low Magnesium Levels Incidence:
29.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
65.0-83.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Paraplatin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5